Skip to main content
logo
Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ: INDV · Real-Time Price · USD
39.29
+0.21 (0.54%)
Aug 18, 2026, 2:11 PM EDT - Market open

Indivior Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
3562107-126-44205
Depreciation & Amortization
172025121319
Other Amortization
1-3333
Loss (Gain) From Sale of Assets
------20
Asset Writedown & Restructuring Costs
27198---
Loss (Gain) From Sale of Investments
-1-9---
Stock-Based Compensation
322624211611
Other Operating Activities
23-45687-110-38
Change in Accounts Receivable
-293-1-33-21-25
Change in Inventory
-118-43-6-30-3
Change in Accounts Payable
-----201
Change in Other Net Operating Assets
-465-278-2-258169-
Operating Cash Flow
-40-2736-300-4353
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-71-66-29-8-5-4
Cash Acquisitions
----129--
Sale (Purchase) of Intangibles
--1-2-45--10
Investment in Securities
1-10084-218-
Other Investing Activities
-11-31-
Investing Cash Flow
-71-6669-95-222-14

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--332--250
Long-Term Debt Repaid
--17-240-12-3-244
Total Debt Repaid
-342-17-240-12-3-244
Net Debt Issued (Repaid)
147-1792-12-36
Issuance of Common Stock
123321
Repurchase of Common Stock
-307-16-195-55-100-101
Other Financing Activities
-151-2---
Financing Cash Flow
-174-30-102-64-101-94

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1-1-1-1-1
Net Cash Flow
-288-1243-458-328244

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-111-937-308-9349
Free Cash Flow Growth
------
Free Cash Flow Margin
-8.34%-7.51%0.59%-28.18%-1.00%44.12%
Free Cash Flow Per Share
-0.86-0.730.05-2.25-0.072.30
Levered Free Cash Flow
86.5221.75147.38-104.5335.5317.63
Unlevered Free Cash Flow
102.38249.88173-82.63352.38328.88

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----18
Cash Income Tax Paid
38384632-17
Change in Working Capital
-495-257-46-297118173
SEC Filings: 10-K · 10-Q